MXiPr Powder
$40.00 – $1,480.00
Formal Name: 2-(isopropylamino)-2-(3-methoxyphenyl)cyclohexan-1-one, monohydrochloride
Synonyms: ​Isopropyloxetamine, MXiPr, 3-methoxy-2-oxo-PCiPr
Molecular Formula: C16H23NO2 • HCl
Purity: ≥98%
Description
MXiPr Hydrochloride (3′-MeO-2’-oxo–PCiPr), adds to our rapidly growing collection of arylcyclohexylamine components with dissociative attributes. MXiPr is a very close advertising agency to MXE and MXPr and shares many of the same properties. Initial trials were positive and we received primary feedback. Many researchers have touched upon the compounds’ similarity to MXE.
While very little research has been done on the substance, it is reported to cause ketamine-like dissociative effects in the laboratory. It will also be structurally similar to phencyclidine (PCP), which was a brand new drug that gained notoriety in 2000 and 1990s for its potential illicit use.
Properties and Effects MXiPr
MXiPR is thought to be a non-competitive NMDA antagonist. This results in a psychedelic feeling. Normal brain activity requires that electrical signals pass through NMDA receptors from the spinal cord to the neurons of the brain. These electrical impulses will not pass if an antagonist is bound. This causes communication to be lost between the higher-order brain functions and the spine cord. This temporary loss in communication is what causes the dissociative condition.
Where to buy MXiPr
Achemic lets you buy research chemicals containing MXiPr directly from our website. Before they are made available for sale, all of our research chemicals have been thoroughly tested. This is how we ensure high-quality MXiPr products. We are happy to answer your questions or provide more information.
This product is only for educational purposes. Achemic doesn’t sell MXiPr except for scientific and educational purposes. Not for human consumption nor veterinarian use. We ship internationally, even to the USA.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.